Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?

AIMS: Since the beginning of the COVID pandemic, studies reported an increase in children’s mental health issues and questioned the impact of SARS‐CoV‐2 on psychiatric symptoms. METHODS: We compared COVID seroconversion in children hospitalized with acute, severe psychiatric symptoms (n = 52) with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayrolles, Anaël, Ellul, Pierre, Trebossen, Vincent, Houhou‐Fidouh, Nadira, Bonacorsi, Stephane, Descamps, Diane, Delorme, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Micro Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216372/
https://www.ncbi.nlm.nih.gov/pubmed/35257512
http://dx.doi.org/10.1002/npr2.12236
_version_ 1784731406949154816
author Ayrolles, Anaël
Ellul, Pierre
Trebossen, Vincent
Houhou‐Fidouh, Nadira
Bonacorsi, Stephane
Descamps, Diane
Delorme, Richard
author_facet Ayrolles, Anaël
Ellul, Pierre
Trebossen, Vincent
Houhou‐Fidouh, Nadira
Bonacorsi, Stephane
Descamps, Diane
Delorme, Richard
author_sort Ayrolles, Anaël
collection PubMed
description AIMS: Since the beginning of the COVID pandemic, studies reported an increase in children’s mental health issues and questioned the impact of SARS‐CoV‐2 on psychiatric symptoms. METHODS: We compared COVID seroconversion in children hospitalized with acute, severe psychiatric symptoms (n = 52) with the sex‐ and age‐matched control group (n = 52) living in the same low‐income geographic area and sampled during the same time period. RESULTS: Contrary to our hypothesis, we observed less seroconverted children with psychiatric conditions 9.61% (95% CI, 3.59‐21.80) vs 34.61% (95% CI, 22.33‐49.16; χ (2) = 14.7, P = 1.24E−4; OR = 0.20; 95% CI, 0.05‐0.64). CONCLUSION: This suggests a lower direct impact of SARS‐CoV‐2 compared with the impact of mitigation strategies on psychiatric symptom deterioration in children reported since early stages of the pandemic.
format Online
Article
Text
id pubmed-9216372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92163722022-06-29 Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children? Ayrolles, Anaël Ellul, Pierre Trebossen, Vincent Houhou‐Fidouh, Nadira Bonacorsi, Stephane Descamps, Diane Delorme, Richard Neuropsychopharmacol Rep Micro Reports AIMS: Since the beginning of the COVID pandemic, studies reported an increase in children’s mental health issues and questioned the impact of SARS‐CoV‐2 on psychiatric symptoms. METHODS: We compared COVID seroconversion in children hospitalized with acute, severe psychiatric symptoms (n = 52) with the sex‐ and age‐matched control group (n = 52) living in the same low‐income geographic area and sampled during the same time period. RESULTS: Contrary to our hypothesis, we observed less seroconverted children with psychiatric conditions 9.61% (95% CI, 3.59‐21.80) vs 34.61% (95% CI, 22.33‐49.16; χ (2) = 14.7, P = 1.24E−4; OR = 0.20; 95% CI, 0.05‐0.64). CONCLUSION: This suggests a lower direct impact of SARS‐CoV‐2 compared with the impact of mitigation strategies on psychiatric symptom deterioration in children reported since early stages of the pandemic. John Wiley and Sons Inc. 2022-03-08 /pmc/articles/PMC9216372/ /pubmed/35257512 http://dx.doi.org/10.1002/npr2.12236 Text en © 2022 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Micro Reports
Ayrolles, Anaël
Ellul, Pierre
Trebossen, Vincent
Houhou‐Fidouh, Nadira
Bonacorsi, Stephane
Descamps, Diane
Delorme, Richard
Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
title Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
title_full Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
title_fullStr Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
title_full_unstemmed Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
title_short Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
title_sort is sars‐cov‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
topic Micro Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216372/
https://www.ncbi.nlm.nih.gov/pubmed/35257512
http://dx.doi.org/10.1002/npr2.12236
work_keys_str_mv AT ayrollesanael issarscov2seroconversionariskfactorforsevereandacutepsychiatricsymptomsinchildren
AT ellulpierre issarscov2seroconversionariskfactorforsevereandacutepsychiatricsymptomsinchildren
AT trebossenvincent issarscov2seroconversionariskfactorforsevereandacutepsychiatricsymptomsinchildren
AT houhoufidouhnadira issarscov2seroconversionariskfactorforsevereandacutepsychiatricsymptomsinchildren
AT bonacorsistephane issarscov2seroconversionariskfactorforsevereandacutepsychiatricsymptomsinchildren
AT descampsdiane issarscov2seroconversionariskfactorforsevereandacutepsychiatricsymptomsinchildren
AT delormerichard issarscov2seroconversionariskfactorforsevereandacutepsychiatricsymptomsinchildren

Ejemplares similares